E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/11/2006 in the Prospect News Biotech Daily.

Hana moves to the Nasdaq under the symbol HNAB

By Elaine Rigoli

Tampa, Fla., April 11 - Hana Biosciences, Inc. has received approval to list its common shares on the Nasdaq under the symbol "HNAB," effective Monday, April 17.

The trading of Hana's shares on the American Stock Exchange will end at the close of business this Thursday afternoon.

Hana is a South San Francisco, Calif.-based biopharmaceutical company that acquires, develops and commercializes products to advance cancer care.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.